Center for Advanced Practice

Title

Ruxolitinib: Targeted Approach for Treatment of Autoinflammatory Very Early Onset Inflammatory Bowel Disease.

Publication Title

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Document Type

Article

PubMed ID

34329777

Abstract

Very early onset inflammatory bowel disease (VEO-IBD), diagnosedold, can be genetically and phenotypically distinct and more refractory than older-onset IBD. Identified causal monogenic defects have been targeted therapeutically in a small subset of VEO-IBD

Funding Information

None.

Keywords

Age of Onset, Child, Crohn Disease, Inflammatory Bowel Diseases, Nitriles, Phenotype, Pyrazoles, Pyrimidines

DOI

10.1016/j.cgh.2021.07.040

Publication Date

6-1-2022

This document is currently not available here.

Share

COinS